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Abstract
Purpose: Glaucoma referral refinement (GRR) has pr ven a successful demand
management strategy for glaucoma suspect cases in the United Kingdom (UK). A
GRR clinic was established in Dublin, Ireland to investigate the clinical viability of
this pathway outside the UK's National Health Service (NHS) structures, and
away from the influence of National Institute for Clinical Excellence (NICE)
guidance.
Methods: Glaucoma suspect patients were recruited into the scheme following
referral from community optometrists in the greater Dublin area. The GRR exam
protocol was designed in consultation with the participating ophthalmology
department. The refinement scheme optometrist, trained through apprenticeship
style experience at a hospital outpatient clinic, made a tentative management
decision after carrying out the GRR exam. The final management decision was
made in a 'virtual clinic' by a glaucoma specialist consultant ophthalmologist.
Results: Two hundred and twenty-five glaucoma suspect patients were seen in the
scheme. After their first GRR visit, 28% were discharged back to their own opto-
metrist, 42% were monitored in the GRR clinic, and 30% were referred to oph-
thalmology. After this monitoring cohort were further assessed, a total of 38% of
the patients seen within the scheme required referral to ophthalmology. Sixteen
percent of the total participant group (n = 225) were lost to follow up. Cohen's K
was used to determine the level of agreement between the scheme optometrist
and ophthalmologist. There was substantial agreement, with K = 0.63 for the first
visit management decisions (n = 225). Agreement increased for subsequent mon-
itoring visits with K = 0.85 for second visits (n = 65), and K = 0.69 for all man-
agement decisions within the scheme (n = 301). We received management
outcomes for 44 of the 86 patients referred to ophthalmology. Of these 44, 57%
received medical treatment for glaucoma, 34% were monitored without treat-
ment, 2% were discharged, and 7% had comorbidities that were assessed and
managed.
Conclusion: Of the patients seen within the scheme, 62% did not require referral
onward to ophthalmology, thus releasing the significant majority of hospital clinic
slots that would previously have been required to examine such patients. The high
level of inter-professional decision agreement likely reflects the benefits of pre-
scheme apprenticeship style training and ongoing hospital clinic participation by
the scheme optometrist. The rate of loss to follow up compares favourably with
ophthalmology led, hospital based, glaucoma clinics. Nevertheless, the losses indi-
cate that patient education remains a key priority for future planning.
Cl 2018 The Authors Ophthalmic & Physiological Optics © 2018 The College of Optometrists
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Introduction
Optometrists play a vital role in the detection of glaucoma,
the world's leading cause of irreversible blindness.1Primary
open angle glaucoma (POAG), the most common glau-
coma sub-type,2 is insidious, progressive and irreversible,
presenting a significant public health challenge.2As popula-
tion screening for POAG detection is neither cost effective3
nor viable,4 it is primarily detected through opportunistic
case-finding during routine eye examinations. Evidence
from the UKs has shown that the vast majority of glaucoma
and ocular hypertension cases are detected through oppor-
tunistic case-finding by community-based optometrists.
Glaucoma prevalence increases exponentially with
increasing age.6 Continued population growth coupled
with our increasing age profile' are accompanied, therefore,
by a synchronous rise in the burden of care required for
glaucoma and other age-related eye disease. In 2014, the
number of people (aged 40-80 years) with glaucoma
worldwide was estimated at 64.3 million, this is expected to
increase to 76.0 million by 2020 and almost double to 111.8
million by 2040.8
Advances in diagnostic and screening tools, such as auto-
mated perimetry, and changes in professional guidance9
with regard to glaucoma diagnosis and management proto-
cols, also have the potential to increase the demand for
glaucoma related care. Clinical guidelines are devdoped
with the aim of improving the quality of care received by
patients and ultimately, improving health outcomes. The
ability of clinical guidelines to deliver on these aims is ques-
tionable, and while appropriate guidelines can be a useful
tool for making care more consistent and efficient, flawed
guidelines have the potential to cause harm to both patients
and the healthcare system.
As an example, in April 2009, the National Institute for
Health and Care Excellence (NICE) guidelines for glau-
coma, 'Glaucoma: Diagnosis and management of chronic
open angle glaucoma and ocular hypertension' were pub-
lished in the UK.10 Although the scope of these guidelines
did not include case-finding or screening for glaucoma,
there was a requirement for all patients with 'repeatable
pressures over 21 mmHg by applanation tonometry to be
assessed by a suitably trained healthcare professional with a
specialist qualification and relevant experience'. This part
of the guidance was interpreted as relevant to case-finding,
and guidance was issued by a group of influential optomet-
ric organisations in the UK, advising optometrists to refer
patients with a repeated lOP reading of above 21 mmHg,
regardless of any other clinical findings. 11 This led to a rise
in glaucoma suspect referrals to ophthalmology and a cor-
responding fall in the positive predictive value (PPV) of the
referrals. J2
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Glaucoma referral refinement (GRR) schemes, which
had emerged in the early 2000s as a potential solution to
the already high rate of false positive glaucoma referrals,13
proliferated in the UK after 2009,14-1' largely in response to
the rise in glaucoma referrals following the publication of
the NICE guidance. GRR describes a two-tier assessment in
which an initial suspicious finding 'is vaIidated by a'subse~
quent enhanced assessment. The aim is to increase the PPV
of optometric referrals to ophthalmology services, which
has been shown to be both clinicallyl8 and financiallyl6.19
viable within the National Health Service (NHS) system.
In Ireland, as with many countries, there are no specific
clinical guidelines relating to glaucoma diagnosis or case
finding in primary care. Although optometric referral pat-
terns in Ireland have not been directly affected by NICE
guidance, anecdotal evidence from the ophthalmology team
within the Mater Misericordiae University Hospital
(MMUH) in Dublin, indicates that the proportion of false
positive glaucoma referrals is high. A recent multicentre
review,20 analysing data from five tertiary referral centres
across Europe, found that only 10% of all newly referred
glaucoma suspect patients actually had glaucoma, confirm-
ing that this issue is common in many jurisdictions.
A number of factors contribute to the false positive glau-
coma referrals from primary care services, including limited
availability of diagnostic equipment and the relatively low
prevalence of glaucoma among the population of patients
seen in optometric practice. Overall POAG prevalence is
estimated at 1.88%, with prevalence rising to 3.2% in those
aged over 70 years. 21 At this prevalence level, even tests
with relatively high sensitivity and specificity will yield low
PPVS.22•23 GRR provides a method of offering enhanced
diagnostic testing to a cohort of glaucoma suspect patients.
In this likely higher prevalence population, the available
diagnostic tests will have better PPV?2.23
The need for demand management within Irish ophthal-
mology services is clear; figures for March 2017, show that
34 675 individuals in the Republic ofIreland (total popula-
tion 2016: 4.76 million24) were on a waiting list for a first
appointment at a consultant-led ophthalmology outpatient
clinic, with 9309 individuals having spent 12 months or
more on the waiting list?S This echoes a pattern of systems
overload that has been demonstrated in many developed.
countries: the need for new, more collaborative care para-
digms in the face of increased longevity and subsequent
increased demand for eye care services has also been recog-
nised in Australia26 and the US.27 Worldwide shortages of
ophthalmologists28 are exacerbating this mismatch between
capacity and demand?9 Strategic planning is needed if we
are to deliver an improved service and avoid an increase in
preventable, visual impairment. This I study.was. designed"
therefore, to -investigate the clinical viability of GRR outside
2 Cl 2018 The Authors Ophthalmic & Physiological Optics@ 2018 The College of Optometrists
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the UK's NHS structures, and away from the influence of
NICE guidance.
Methods
The project began as a collaboration between researchers
and cliiJicians at the Dublin Institute of Technology (DIT)
and the Mater Misericordiae University Hospital (MMUH)
Dublin. It was agreed that a GRR scheme could be of bene-
fit to the ophthalmology department and the National
Optometry Centre (NOC) at DIT agreed to host the
scheme. The project was established as part of a PhD pro-
ject examining glaucoma case finding by optometrists in
Ireland. The research student, being an optometrist,
became the scheme's specialist optometrist in glaucoma
(SOG). A 2 month period of pre-scheme training
commenced in October 2011. This consisted of at home
self-study and apprenticeship-style training through partic-
ipation in consultant led hospital glaucoma clinics. This
apprenticeship style training began with observation of
senior medical staff and progressed towards independent
examination of patients and case presentation by the SOG
to the supervising consultant. This process of supervised
practice was key to the development safe decision-making
skills. There was no formal evaluation or assessment of the
performance of the SOG before they began examining
patients under the glaucoma referral refinement and moni-
toring service (GRRMS). The scheme began when the
supervising ophthalmologist considered the SOG was
ready, which was agreed after 24 h of training across six
clinic sessions. It is recognised that this training and accred-
itation process would need to become more standardised if
the scheme was to be expanded, but this arrangement was
deemed appropriate for this process given that the detailed
one to one supervision allowed the consultant to closely
monitor and assess the SOG's ongoing performance. The
SOG continued to attend one clinic session per week
throughout the duration of the scheme, examining both
glaucoma patients and suspects under the supervision of a
glaucoma specialist consultant ophthalmic surgeon.
The pilot scheme was announced to Irish optometrists
through email leaflets, a publication in the periodical jour-
nal of the Association of Optometrists Ireland (AOI), and a
presentation at the AOI annual general meeting in Novem-
ber 2011. Glaucoma suspect patients were recruited into the
scheme following referral from community based optome-
trists in the greater Dublin area. Optometrists were
instructed that any new glaucoma referrals were eligible for
the scheme though urgent cases should be directly referred
to ophthalmology as usual. This study sought to investigate
the clinical viability of GRR away from the influence of
NICE guidance and the subsequent guidance from profes-
sional representative bodies in the UK,30 therefore there was
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no specific guidance issued to community optometrists as
to which clinical findings warranted referral to the GRRMS.
The purpose of the study was explained to each patient
both verbally and through a written consent form. Only
those who gave written consent to have their clinical infor-
mation used in the study were included in the analysis.
The GRRMS exam was designed to 'include gold standard
examination strategies; both NICE10 and European Glau-
coma Society (EGS) guidelines3! were referred to in the
process of drafting the examination protocol. This also
resulted in the examination protocol aligning well with the
current practice within the participating ophthalmology
department, which provided reliable baseline information
for patients that were referred to ophthalmology after the
refinement exam. The agreed GRRMS exam included the
following assessments:
1. Case history.
2. Anterior chamber slit lamp examination, including Red-
mond Smith ~!1d ~~n !lerick's tEchni<I.ues.
3. Goldmann tonometry.
4. Ultrasound pachymetry.
5. Visual field test (Humphrey Visual Field Analyser SITA-
Fast 24-2).
6. Dilated, slit lamp indirect ophthalmoscopy exam.
7. Fundus photography.
While the refinement scheme optometrist made a prelimi-
nary management decision after the GRR exam, the final
management decision was approved by a glaucoma special-
ist consultant ophthalmic surgeon, who acted as the
scheme's reference standard. Digital fundus photographs,
copies of the visual field plots, and a summary of the
patient record which included case history information, slit
lamp findings, intraocular pressure (lOP) and pachymetry
readings, and the optometrist's written record of the optic
disc assessment, were made available for the consultant to
view in a 'virtual clinic', similar to that described by Trikha,
et al.!4 and Kotecha, et al.32 following the patient's GRR
exam. Patients were informed of their final management
through phone calls from the scheme optometrist.
The clinical outcomes for the patients seen in the scheme
were categorised into three broad groups:
1. Discharge from the GRR clinic back to the primary
optometrist;
2. Monitor in the GRR clinic;
3. Refer to ophthalmology.
It was decided that <:linical guidelines indicating specific
clinical findings at which to refer, monitor or discharge
would be either unmanageably large or harmfully oversim-
plified, and could not represent best practice for many indi- .
vidual patients. For clinical tests such as lOP' Oli cup-disc \
ratio (CDR) for example, there are no set values that can
@ 2018 The Authors Ophthalmic & Physiological Optics 11:1201 8 The College of Optometrists 3
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perfectly discriminate between early glaucoma and those
who are non-glaucomatous. Thus, the scheme proceeded
with no set protocols beyond defining the tests that should
be carried out, and the clinicians made their management
decisions after taking all of the relevant clinical findings
into consideration.
The oata collected were'analysed on the'softWare package
for social sciences, IBM SPSS Statistics (www.ibm.com). A
frequency analysis was run to determine the management
outcomes within the scheme, One-way Welch's analysis of
variance (ANOVA), Kruskal-Wallis H Test and Cohen's
kappa (K) were used to further analyse the results.
Results
Two hundred and twenty-five patients were recruited into
the scheme. The management outcomes are outlined in
Table 1.
A proportion of those patients assigned to be monitored
within the GRR clinic were lost to follow up. These were
lost exclusively from the monitoring cohort who were not
diagnosed with glaucoma but advised to continue regular
monitoring of suspect features. Approximately one-third of
those recalled dropped out at each monitoring interval.
The exact figures are shown in Table 1 above. Overall, 16%
of participants were lost to follow up.
Of the 225 patients seen within the scheme, 80 were
referred to ophthalmology as glaucoma suspects, two of
these 80 had comorbidities that were detected during the
GRR exam, both choroidal naevi. A further six patients
were confirmed as non-glaucomatous during their GRRMS
exam though comorbidities were detected which were
deemed to require referral. Of these six, two were ocular
naevi and the remainder ranged in severity from a routine
referral for medical management of severe blepharitis to a
neuro-ophthalmology referral for suspect neurological field
loss.
Table 1. Management outcomes from the Dublin GRR clinic. Percent-
ages have been rounded to the nearest whole number resulting in some
percentage totals differing from 100%
End of
Visit 1 Visit 2 Visit 3 study
(n = 225) (n = 95) (n = 16) (n = 225)
Discharge n (%) 62 (28%) 34(36%) 5 (31 %) 101 (45%)
Monitor n (%) 95 (42%) 16 (17%) 3 (19%) 3(1%)
Refer n (%) 64 (28%) 13 (14%) 3 (19%) 80 (35.5%)
R~fer 4 (2%) ' __ 2(2%) o(0%) 6(2.6%)
comorbidity n (%)
Lost to 30t (32%) 5(31%) 35 (16%)
follow up n (%)
'One patient in this cohort emigrated during the study and continued
their care abroad,
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Therefore, 86 patients were referred onwards from the
scheme, 38% of the total group.
Clinical variations between management groups
A one-way ANOVA was conducted to determine if central
corneal thickness (CCT), lOP, 'and vertical cup-disc ralio
(vCDR) were different for the three core management
groups based on the first visit management decision (dis-
charge n = 66, monitor n = 95, refer n = 64). In cases
where the referral indicated bilateral suspicious findings,
the more suspect eye was chosen as the study eye, or, if the
clinical findings were equivalent in each eye, the study eye
was randomly selected through a coin toss.
One outlier was removed from the CCT data as the
patient had a pathologically thin cornea following previous
ocular injury. Two more outliers were found, as assessed by
inspection of a boxplot for values greater than 1.5 box-
lengths from the edge of the box. However, these data
points were kept in the analysis as they represented the
wide range of CCT values present in a normal population.
The CCT values were normally distributed, as assessed by
visual inspection of the Q-Q plots. There was homogeneity
ofvariances, as assessed by Levene's test for equality ofvari-
ances (p = 0.97). The differences in mean CCT between the
management groups were not statistically significant, F(2,
221) = 1.382, P = 0.25 (see Table 2).
There were no outliers in the lOP data and values in each
cohort were normally distributed, as assessed by visual
inspection of boxplot and Normal Q-Q plots respectively.
The assumption of homogeneity of variance was violated,
as assessed by Levene's test for equality of variances
(p = 0.001). The difference between mean Goldmann lOP
in the three management groups was statistically significant
using Welch's ANOVA, Welch's F(2, 37.22) = 129.21,
P < 0.0001 (see Table 2). lOP increased from the discharge
(n = 66, M = 16.26 mmHg, S.D. = 3.13); to monitor
(n = 95, M = 18.32 mmHg, S.D. = 3.47); to refer (n = 63,
M = 22.83 mmHg, S.D. = 5.22) management groups, in
that order (see Figure 1b and Table 2). Games-Howell post
hoc analysis revealed that the mean increase from the dis-
charge to monitor groups (2.06 mmHg, 95% Cl [0.82,
3.30]) was statistically significant (p < 0.0001), as was the
increase from monitor to refer (4.51 mmHg, 95% Cl [2.73,
6.29], P < 0.0001).
Welch's ANOVA was then repeated to determine if mean
lOP was statistically significantly different for the three core
management'ilroups based on the second visit management
decision (discharge n = 35,1 M = 16.4 mmHg,
S.D. = 2.2); (monitor n = 16, M = 19.1, S.D. = 4.6); (refer
n = 13, M b_.?QJ5, S.R._~ 5.2).Th~_dilfe!e!1se betweel). _
. "
'One outlier was removed from this group.
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Table 2. A one-way ANOVA comparing the clinical findings for central corneal thickness (CCT), intraocular pressure (lOP)·.. and vertical cup-disc ratio
(vCDR) according to the first visit management group within the refinement clinic
Discharge (n - 66) Monitor (n = 95)t Refer (n - 64) P value (ANOVA)
CCT 570 Jlm (±39.63) 569 Jlm (±38.41) 560 Jlm (±40.06) 0.25
Mean (S.D.)
lOP 16.26 mmHg (±3.13) 18.32 mmHg (±3.47) 22.83 mmHg (±5.22). ~ J ',.~ <0.0001
",
Mean (S.D.)
vCDR 0.38 (±0.17) 0.48 (±0.17) 0.54 (±0.18) <0.0001
Mean (S.D.)
·Welch's ANOVA.
11 tOne outlier was removed from the CCT data, n for the CCT monitoring cohort was 94.
(b) (e)
25 0.60
Q.. uIII
0>- 23 :g 0.50
-. '.C>- 10.>-C'O 20 :J. 0.40
":J u>-E ... -'0
'0 11I 18
. ~~ 0.300""":' t!1II(!)l:ll
15 .g 0.20CL >0:;
"E c"liE 13 " .. 0.10::E ..... III
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Figure 1. Mean values for central corneal thickness, intraocular pressure (lOP), and vertical cup-disc ratio (vCDR) in each first visit, refinement clinic
management group (discharge n = 66. monitor n = 95. refer n = 64).
mean second visit Goldmann lOP values in the three
management groups was again found to be statistically sig-
nificant, Welch's F(2, 20.50) = 5.27, P = 0.014, but
Games-Howell post hoc testing showed no statistically sig-
nificant pairwise comparisons. These apparently conflicting
results are due to the differences in the distributions used
in the one-way ANOVA and the Games-Howell post hoc test
and show that a statistically significant difference between
groups is questionable.
There were no ouiliers in the vCDR data and values in
each cohort were normally distributed, as assessed by visual
inspection of boxplot and Normal Q-Q plots respectively.
There was homogeneity of variances, as assessed by Levene'
test for equality of variances (p = 0.45). There was a statis-
tically significant difference between the three groups, F(2,
222) = 14.97, P < 0.0001 (see Table 2). vCDR increased
from the discharge (n = 66, M = 0.38, S.D. = 0.17); to
monitor (n = 95, M =0.48, S.D, =0.17); to refer (n = 64,
M = 0.54, S.D. = 0.18) management groups, in that order
(see Figure le and Table 2). Tukey-Kramer post hoc analy-
sis revealed that the increase from the discharge to monitor
groups (0.10, 95% Cl [0.03, 0.16]) was statistically signifi-
cant (p = 0.001), though the increase from monitor to refer
(0.06, 95% Cl [0.001, 0.130], P = 0.055) was not. The dif-
ference between the discharge and refer groups was signifi-
cant at the p < 0.0001 level (0.16, Cl [0.09,0.23]).
The one way ANOVA was then repeated to determine if
mean vCDR was statistically significantly different for the
three core management groups based on the second visit
management decision (discharge n = 36, M = 0.50,
S.D. = 0.14); (monitor n = 16, M = 0.45, S.D. = 0.19);
(refer n = 13, M = 0.49, S.D. = 0.06). The difference
between mean second visit vCDR values in the three man-
agement groups was not found to be statistically significant,
F(2,23.70) = 0.50, P = 0.62.
It was not possible to include visual field results in the
ANOVA analysis as visual inspection of the normal Q-Q plots
for all three global indices (visual field index (VFI), mean
deviation (MD), and pattern standard deviation (PSD))
showed that the data was not normally distributed. For this
non-parametric data, a Kruskal-Wallis H Test was used to
determine if there were significant differences between the
medians of the three management groups. The PSD score
was chosen as the global index most relevant to early glau-
coma. Distributions of PSD scores were similar for all
groups, as assessed by visual inspection of a boxp)ot.
@2018 The Authors Ophthalmic & Physiological Optics@ 2018 The College of Optometrists 5
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Agreement between ophthalmologist and optometrist
management decisions
Median PSD scores were statistically significantly different
between groups, H(2) = 11.251, P = 0.004. Pairwise com-
parisons were performed using Dunn's (1964) procedure
with a Bonferroni correction for multiple comparisons. Sta-
tistical significance was accepted at the p < 0.0167 level.
This post hoc analysis revealed statistically significant differ-
ences'in median PSD scores betWeen the discharge (1.47)
and refer (1.81) (p = 0.004) management groups, but just
approached significance between the monitor (1.51) and
refer groups (p = 0.024), and no significant difference was
observed between the monitor and discharge groups
(p = 1.00).
This test was then repeated to determine if the differ-
ences in median PSD score were still statistically significant
for second visit management decisions (discharge n = 35,
monitor n = 16, refer n = 19) which showed that median
PDS scores were not statistically significantly different
between the groups, H(2) = 0.783, P = 0.68.
Cohen's kappa (K) was used to determine if there was
agreement between the scheme optometrist and ophthal-
mologist. There was substantial agreement,33 with K ~ 0.63
for all patient visits (Table 3).
The cross tabulation (Table 4) shows where the disagree-
ments occurred.
Table 4 shows that there were 35 decisions where the
scheme's reference standard, a glaucoma specialist consul-
tant ophthalmic surgeon, had more conservative clinical
management than tR@llOG,....These 35 decisions represent 33
patients as there were two occasions where disagreement
was on the same patient at different visits. Of the 33
patients, seven were eventually discharged from the scheme,
seven failed to return for their follow up appointments, and
19 were eventually referred to ophthalmology. Of these 19,
we were able to follow up on ophthalmology management
outcomes for just seven patients: two were started on treat-
ment, four were monitored in ophthalmology, and one was
discharged. The two patients who received treatment in
ophthalmology had been marked for monitoring by the
SaG. There was one occasion where a patient was marked
for discharge by the SaG but subsequently referred to oph-
thalmology by the scheme's supervising ophthalmologist
(Table 4), the management outcome for this patient was
not available to us. We were able to follow up on manage-
ment outcomes for 44'df the 86' patients' referred 'to oph:
thalmology (Table 5).
Discussion
Only 38% of the patients seen in the scheme required refer-
ral for specialist hospital care demonstrating the scheme's
significant potential to release capacity within hospital eye
services. Those patients referred to ophthalmology had sig-
nificantly improved clinical information, including full
threshold visual fields on the Humphrey Visual Field Anal-
yser, Goldmann tonometry readings, and ultrasound
pachymetry measurements. Providing all of these tests
within one GRR appointment creates a reliable baseline for
future monitoring and negates the need for those patients
to have separate appointments for different diagnostic tests
such as visual field testing for example, which is often the
case within the MMUH glaucoma clinic. With further
training, the scheme could be further expanded to include
optical coherence tomography (aCT) and gonioscopy so
that the GRRMS could serve to provide best practice diag-
nostic testing for glaucoma suspects outside of the ophthal-
mology outpatient clinic, a model that has worked well
elsewhere?6
Of the eight co-morbidities detected in the scheme, four
were retinal naevi. Future schemes should define a manage-
ment protocol for this relatively common condition.
The first visit discharge rate (29%) is similar to rates doc-
umented in the UK after the NICE guidelines, 'Glaucoma:
Diagnosis and management of chronic open angle glau-
coma and ocular hypertension' were published,16 an
important finding in a jurisdiction that has no specific clin-
ical guidelines relating to glaucoma diagnosis or case-find-
ing. Sparro~ argued that 'hasty and ill-considered advice
... (to optometrists by influential professional bodies) ...
produced an ongoing problem of unnecessary flooding of
NHS glaucoma services, with false positive referrals fre-
quently based on poor quality lOP measurements'. While
there is truth in this statement, it is not the whole truth, as
it places a distorted and arbitrary focus on false positive
referrals and ignores the difficult role optometrists have in
balancing their clinical judgement and-their legal-responsi-
bilities. Optometrists have a responsibility to detect disease
during routine eye examination, which inherently leads to
false positive referrals in a population where the relative
prevalence of'glaucoma is low.22 This effect is likely being
compounded by a tendency for optometrists-to preference
All
management
decisions
(n - 301)
0.69
(0.62-0.89)
P < 0.0001
79.4%
Visit 3
(n - 11)
0.72
(0.36--1.08)
P = 0.001
81.8%
Visit 2
(n - 65)
0.85
(0.73-0.97)
P < 0.0001
90.8%
0,63
(0.54-0.72)
P < 0.0001
76.0%
Visit 1
(n - 225)
Kappa
(95%(1)
p
Rate of
agreement
Table 3. Inter-rater agreement within the virtual clinic
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Table 4. Cross tabulation showing the optometrist's preliminary management decision (rows), and the final management decided by glaucoma con-
sultant (columns)
Optom d~ision
Total
Total
103
68
130
301
Agreement is shaded in grey. Underlined figures represent occasions where the ophthalmologist was more conservative than the scheme
optometrist.
Table 5. Management outcomes for patients referred to
ophthalmology
Management outcome n %
Medical treatment 25 57
Monitored without treatment 15 34
Djscharg~d at first visit 1 2
Managed co-morbidity 3 7
Total 44 100
sensltlVlty over specificity in their diagnostic testing,35 a
practice pattern that could be considered pragmatic, given
that optometrists are required to detect pathology and are
at risk oflitigation36,37 if they fail in this duty of care. Opto-
metrists are faced with a paradoxical situation whereby rig-
orous, highly sensitive screening can often lower overall
referral accuracy as it produces a high number of false posi-
tives, but the alternative, highly specific screening poten-
tially increases the risk of missing disease that could lead to
irreversible sight loss.
A number of approaches have failed to solve the problem
of false positive glaucoma referrals. Vernon and Ghosh38
established that the provision of specific referral guidelines,
circulated to all optometrists working within the catchment
area, had little effect on the proportion of false positive
referrals. Yoshioka, et ae9 showed that short-term didactic
teaching programs had most effect on false negative rates in
glaucoma referrals. This indicates that training may have a
beneficial impact on the prevalence of undetected glau-
coma, but is unlikely to significantly reduce false positives.
GRR provided a safe method of offering enhanced diagnos-
tic testing to a cohort of glaucoma suspects. In this likely
higher prevalence population, the available diagnostic tests
can produce better PPVS.23.40
Of courseno medical test has perfect sensitivity and per-
fect specificity, and glaucoma detection is a particularly
ambiguous area given the significant overlaps in the clinical
features of suspicious, but normal individuals and those
with early glaucoma.22,39 Accurate diagnosis of early
glaucoma often requires careful monitoring until progres-
sion, the hallmark of glaucoma, can be identified or ruled
OUt,41 Our results have highlighted the existence of a moni-
toring need in suspect glaucoma (Table 1), and careful con-
sideration should be given to how this cohort of patients
can be best served.
Recent changes in the legislation governing optometric
practice in Ireland, has framed scope of practice more
broadly.42 This has created the potential for optometrists to
become more involved in the diagnosis, monitoring and
management of ocular pathology, as has happened in many
other jurisdictions including Australia,43 the UK44.45 and
the USA.46
There is a skills and experience gap however, in moving
from a screening role to an enhanced diagnostic or man-
agement role: a recent survey about the barriers perceived
by optometrists in relation to glaucoma care found a
majority of Irish optometrists agreed that a lack of training
limited their ability to detect glaucoma during routine eye
exams.47 Our collaborative care scheme allowed for opto-
metric skill and equipment to be utilised in collaboration
with ophthalmology expertise and experience, delivering
better access to expert care, while ongoing hospital-based
apprenticeship style training for the scheme optometrist
facilitated real improvements in optometric clinical skill,
which cannot be achieved through didactic training pro-
grammes alone.39
The level of inter-observer agreement (K ~ 0.63 for all
patient visits, Table 3) was substantial, which likely reflects
the benefits of pre-scheme apprenticeship style training and
ongoing hospital clinic participation by the scheme opto-
metrist, which ensured adequate glaucoma experience,
while also facilitating communication between optometry
and ophthalmology, as recommended by Lockwood,
et al. 18 and Trikha, et al. 14 A higher level of agreement was
achieved for those who were monitored (K = 0.85 for sec-
ond visit management decisions, Table 3). This aligns with
the findings from Wright and 'Diamond48 who observed a
kappa value of 0.69 for monitoring reviews of glaucoma
patients and suspects.
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Some amount of disagreement in relation to glaucoma is
to be expected from the scheme. It is well recognised that
decision making algorithms in glaucoma are complex, and
that even glaucoma specialist ophthalmic consultants exhi-
bit a wide range of agreement with each other, and even
themselves, when diagnosing or managing the condition.49
The most common area of disagreement was between the
discharge and monitor groups, likely due to the ambiguity
in these suspect cases. There was one occasion where a
patient was non-conservatively marked for discharge by the
optometrist but subsequently referred to ophthalmology by
the scheme's supervising ophthalmologist. Although the
management outcome was not available to us for this iso-
lated case, this example does highlight the advantage of
close inter-professional cooperation and the utility of vir-
tual clinic reviews in ensuring patient safety in the scheme.
Substantial agreement was achievable despite the lack of
predefined management protocols within the scheme. The
clinical measurements for lOP, vCDR and PSD showed sta-
tistically significant differences between first visit manage-
ment groups but the observed differences just failed to
reach statistical significance at the second visit. It is possible
that a larger sample size in the second visit cohort would
have achieved statistical significance as the data is trending
in this direction. This perhaps confirms that guidelines
may be broadly applicable to a large cohort of patients, but
not appropriate in many individual cases, particularly more
ambiguous presentations that require monitoring. Alterna-
tively, these results could represent the historical reliance
on these measurements in glaucoma diagnosis. It is cur-
rently understood that these markers are not sufficient to
characterise such a complex disease. Thus, clinical judge-
ment needs to supersede guidelines at times. In fact, the
diagnostic criteria for glaucoma have varied widely between
studies: Wolfs, et al,50 estimated that the overall prevalence
of POAG may vary up to 12-fold with different criteria and
screening algorithms.
It is notable that 33% of those we were able to follow up
in ophthalmology were monitored without treatment
(Table 5) even when a glaucoma subspecialist recom-
mended they were referred (essentially a false positive oph-
thalmology referral, which provides further evidence as to
the difficulty in finding the right sensitivity-specificity bal-
ance). This reflects the gap between the sensitivity required
when screening for glaucoma and the specificity required
when making decisions regarding treatment. We believe
that the GRRMS provides a way to manage this sensitivity-
specificity paradox, which may not be achievable by other
means. In fact, emphasis on false positive referrals could
create a culture of diminishing sensitivity, where optomet-
ric glaucoma referrals are very specific, but glaucoma diag-
noses are missed because of reluctance to refer or inability
to carry out appropriate follow up investigations.
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Approximately 50% of those with glaucoma in Ireland21
and other developed countries51 are unaware of their dis-
ease. To reduce visual impairment and thus loss of inde-
pendence in the aging population, detection of OAG is of
utmost importance. Rather than placing arbitrary focus on
false positive referrals, the scheme facilitated open commu-
nication betWeen those screening for the' disease and those
responsible for treatment, as well as clearer acknowledge-
ment and planning for the necessary work of monitoring
suspect cases.
On first review, the dropout rate (approximately one-
third of patients in the monitoring group, see Table 1) may
be a cause for concern. However, the rate of loss to follow
up actually compares favourably with ophthalmology led,
hospital based glaucoma clinics,52 demonstrating a poten-
tial advantage of community based care. A similar loss to
follow up for glaucoma suspect patients was reported in an
optometry-led collaborative glaucoma care scheme in Aus-
tralia.l6 It has been documented that glaucoma suspects are
significantly more likely to drop out oHollow up cO\l1pared .. -
to those with established glaucoma53 and that patients'
understanding of glaucoma disease mechanisms, including
the insidious and irreversible nature of the condition, has
been shown to greatly influence their adherence to recom-
mended follow-up visits.54 This indicates that improved
patient education and emphasis on good physician-patient
communication should be a key priority for future
planning.
Limitations
The voluntary nature of the study could have affected the
sample of referrals obtained. The scheme was established
through voluntary participation from optometrists and
patients within the greater Dublin area. As referral to this
scheme was optional, optometrists may have referred more
highly suspect patients to ophthalmology preferentially,
seeing referral to a refinement clinic as unnecessary when
they were certain of their diagnosis. Access to all glaucoma
referrals during the study time period would likely better
represent the true nature of optometric referrals in Ireland.
It should be noted however, that the referrals did represent
a broad spectrum of glaucoma, from early to advanced
stages.
Lack of access to ophthalmology patient records also lim-
ited the documentation of the final ophthalmology man-
agement outcomes for the referred patients and made it
impossible to assess the positive predictive rate (PPR) of
the refined referrals. The scheme operated with cooperation
from the glaucoma team at the MMUH, so we were able to
access outcomes for the cohort of patients that were su\:lse-
quently seen in the outpatient glaucoma clinic at \the
MMUH. Some of the patients referred into the scheme
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were not within the MMUH catchment area. If these
patients required referral to ophthalmology, they were sent
to the appropriate public ophthalmology service, or if they
so wished, to a suitable private ophthalmology service.
Feedback from these services was difficult to attain, it was
dependent on individual doctors within the services send-
ing' a response back to the SOG. Historically, optometry
has remained a community-based profession in Ireland,
and not been integrated into hospital services. Therefore,
optometrists typically have no access to hospital eye service
records and only sporadic feedback from the public oph-
thalmology services to which they refer. Initial findings
indicate a high level of accuracy within the refined referrals,
with only one patient being discharged from ophthalmo-
logical review at first visit. The PPV of GRR schemes has
previously been calculated at 0.78,14 a marked improve-
ment over unrefined glaucoma referrals (0.37).18 Further
work needs to be done on the follow up of glaucoma refer-
rals within an Irish hospital eye service. Determining the
PPV for both refined and unrefined optometric glaucoma
referrals in Ireland would give more insight into the value
of the Dublin GRRMS.
The agreement rate between clinicians was high, but the
scheme involved just one ophthalmologist and one opto-
metrist. It might not be possible to achieve this level of
agreement once the scheme is expanded. Furthermore, the
scheme optometrist was involved in this project as part of
their PhD research and therefore may have been more
invested in the training and literature review than might be
typical of most community based optometrists. Future
work should continue to assess inter-practitioner agree-
ment to determine whether agreement remains high when
multiple clinicians are employed.
The false negative rate of the scheme was not assessed. It
is possible that some true glaucoma cases were discharged
from the scheme. All patients who were discharged from
the GRRMS were advised to visit their optometrist for
annual or biennial eye exams in the future and a detailed
report of the GRRMS findings was sent to the referring
optometrist. The false negative rate from similar schemes
has been reassuringly low,40,ss though the sample sizes in
these false negative studies have also been low, leaving some
uncertainty regarding the true false negative rate of GRR
schemes. Any expansion ofthe Dublin GRRMS should look
to incorporate a mechanism to assess false negatives.
While similar initiatives have produced substantial cost
savings for the state,14,17 future work should provide an
economic evaluation of the sefteme. The cost effectiveness
of GRR schemes has been shown to vary significantl~
depending on the financial models used. The national aver-
age cost of an outpatient visit in Ireland was estimated to
be £130 in 2011 using a top-down methodology (National
Casemix Programme) however, no information is available
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on how this cost may vary across specialties. This is approx-
imately treble the amount currently paid by the State for
dilated eye examinations conducted by community opto-
metrists (£45). Costing an outpatient ophthalmology clinic
appointment will be an important step in assessing the
financial viability of any community based ophthalmic
shared-care' scheme in Ireland~ but it appears likely that
such a scheme could generate cost savings.
Conclusions
The GRRMS proved a safe and effective collaboration
between optometry and ophthalmology, facilitating com-
munity refinement and monitoring of the majority of glau-
coma suspect patients. Current waiting times for state
funded ophthalmology-led clinic appointments are at
unacceptable levels, in excess of 18 months in some hospi-
tals,2S leaving vulnerable patients at risk of permanent sight
loss. The monitoring facility in this scheme acted to bridge
the gap between the sensitivityJequired 'when case finding
for glaucoma and the specificity required when initiating
treatment. This pilot scheme confirms that there is poten-
tial for GRRMS to release capacity within hospital outpa-
tient clinics, although we cannot be sure what affect this
might have on waiting lists until a larger scheme is imple-
mented. Pending economic evaluation, state agencies
should consider how care structures could be modified to
support further development of GRRMS in Ireland.
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